Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_assertion type Assertion NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_head.
- NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_assertion description "[Alzheimer disease neuropathology is common in Down syndrome patients at relatively early ages, and it has thus been speculated that BACE2 co-overexpression with APP would promote the early neurodegenerative phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_provenance.
- NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_assertion evidence source_evidence_literature NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_provenance.
- NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_assertion SIO_000772 19840121 NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_provenance.
- NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_assertion wasDerivedFrom befree-20150227 NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_provenance.
- NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_assertion wasGeneratedBy ECO_0000203 NP879001.RAckhrUwEU7xI6JSDVSZk-O7KsWk91BDiBmNpNVl9VOEw130_provenance.